Fig. 11
From: Molecular docking and dynamics reveal novel CDK6 inhibitors for targeted glioblastoma therapy
Graphical representation of principal components (PCs) for both, lead compound 21 and CCL across PC1, PC2, and PC3.
Fig. 11 | Scientific Reports
